White House Details COVID-19 Strategy for Winter

White House Details COVID-19 Strategy for Winter

On Thursday, President Joseph R. Biden, Jr. announced a series of new actions to protect Americans from COVID-19, including the Delta and Omicron variants, this winter. The Administration’s new actions come as additional cases of the Omicron variant continue to be identified in the U.S. and globally. The new set of actions include: Boosters for…

Read More »

CDC Updates COVID-19 Booster Recommendations

On Monday, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky announced the CDC has strengthened its recommendation for booster doses for individuals ages 18 and older. Per the CDC, everyone ages 18 and older should get a booster shot either when they are six months after their initial Pfizer or Moderna…

Read More »

Pfizer-BioNTech Request EUA Expansion for Adolescent Boosters

This week, Pfizer and BioNTech submitted a formal request to the U.S. Food and Drug Administration (FDA) to expand the emergency use authorization (EUA) of a booster dose of the COVID-19 vaccination to include individuals ages 16 and 17. Currently, only people ages 18 and older are eligible for a COVID-19 booster dose in the…

Read More »

DHCS Joins CMS Group on Quality Improvements for Well-Child Visits

The California Department of Health Care Services (DHCS) was recently accepted into the U.S. Centers for Medicare & Medicaid Services’ (CMS) Infant Well-Child Visits Learning Collaborative Affinity Group. The group is part of CMS’ Maternal and Infant Health Quality Initiative, which is intended to support states in implementing quality improvement projects that improve the utilization…

Read More »

FDA Panel Narrowly Recommends First Oral COVID-19 Antiviral Treatment

On Tuesday, the U.S. Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) narrowly recommended that the agency issue its first emergency use authorization (EUA) for Merck’s investigational oral antiviral medication for the treatment of mild to moderate COVID-19 in adults with high risk of severe COVID-19 or hospitalization. The drug, molnupiravir, has been…

Read More »

Biden-Harris Administration Issues National Action Plan to Combat Human Trafficking

Today, the Biden-Harris Administration announced the release of the new National Action Plan to Combat Human Trafficking, detailing the country’s strategy to addressing human trafficking. The plan delineates actions and resources across numerous federal agencies and emphasizes collaboration with state and local governments, the private sector, and non-governmental partners. The National Action Plan retains a…

Read More »